Aflac stock (US0010551028): Japan Post trust discloses 10% stake

Aflac shares traded at $115.48 recently amid news of J&A Alliance Holdings, linked to Japan Post, reporting a 10.14% passive stake per SEC Schedule 13G/A filing as of April 28, 2026.

Aflac Incorporated, trading on the NYSE under ticker AFL, saw recent attention from a regulatory filing where J&A Alliance Holdings disclosed a 10.14% passive stake in the company, according to an SEC Schedule 13G/A as of May 2026. The filing indicates 51,636,945 shares held based on outstanding shares as of April 28, 2026. Separately, a Japan Post-related trust sold 24,100 shares at prices between $113.38 and $115.54, per SEC Form 4 data.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Aflac Incorporated
• Sector/industry: Life & Health Insurance
• Headquarters/country: United States
• Core markets: US and Japan
• Home exchange/listing venue: NYSE (AFL)
• Trading currency: USD

Aflac: core business model

Aflac Incorporated provides supplemental health and life insurance products, primarily in the United States and Japan. The company offers policies covering cancer, accident, hospital, life, and dental expenses, targeting gaps in primary insurance coverage. Aflac operates through two main segments: Aflac Japan and Aflac U.S., with Japan contributing the majority of premiums. This dual-market focus exposes the company to both U.S. healthcare dynamics and Japanese demographics.

Main revenue and product drivers for Aflac

Revenue stems mainly from insurance premiums, investment income, and fees. In recent periods, Aflac reported revenue growth of 27.9% year-over-year, alongside a return on equity of 13.88% and net margin of 25.60%, per financial data cited in MarketBeat as of May 2026. Key products include cancer insurance, which remains a bestseller in Japan, and voluntary benefits in the U.S. workplace market. The stock traded at $115.48 USD on NYSE recently, according to StockInvest.us as of May 13, 2026.

Industry trends and competitive position

The supplemental insurance sector benefits from rising healthcare costs in the U.S., driving demand for Aflac's products among employers offering voluntary benefits. In Japan, an aging population supports steady premium growth. Aflac holds a leading position in cancer insurance domestically and competes with firms like Prudential and MetLife in the U.S. Its focus on awareness campaigns, such as the Aflac Cancer Initiative honoring figures like Adamari López, bolsters brand visibility, per Simply Wall St news.

Why Aflac matters for US investors

Aflac's NYSE listing and significant U.S. operations make it relevant for American portfolios seeking exposure to stable insurance cash flows. With half its business in Japan, it offers diversification amid U.S. market volatility, while dividends appeal to income-focused investors. The recent 10% stake disclosure by a Japan Post-linked entity underscores ties to its key market.

Conclusion

Aflac continues to navigate its dual-market model amid stake disclosures and insider activity, with recent trading around $115 reflecting market stability. Financial metrics show resilience, including strong revenue growth and margins, while initiatives like cancer awareness maintain relevance. US investors track its performance for insurance sector exposure and Japan diversification.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.